Crh Medical Revenue Growth Rates (CRHM), Current and Historic Growth - CSIMarket
CSIMarket
 


Crh Medical Corporation  (NYSEAMER: CRHM)
 

CRHM's Revenue Growth by Quarter and Year

Crh Medical's Revenue results by quarter and year




CRHM Revenue (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
4th Quarter December 36.78
3rd Quarter September 30.35
2nd Quarter June 13.58
1st Quarter March 25.45
FY 106.16





CRHM Revenue fourth quarter 2020 Y/Y Growth Comment
Crh Medical Corporation showed record Revenue growth in the fourth quarter 2020 with 21.12% from the fourth quarter 2020 2019, to $ 36.78 millions.

Looking into fourth quarter 2020 results within Medical Equipment & Supplies industry 47 other companies have achieved higher Revenue growth. While Crh Medical Corporation' s Revenue rise of 21.12% ranks overall at the positon no. 965 in the fourth quarter 2020.




CRHM Revenue ( Y/Y Growth %) 2020
2019 2018 2017
4th Quarter December 21.12 % -5.15 % - -
3rd Quarter September -0.2 % 5.85 % - -
2nd Quarter June -55.45 % 11.53 % - -
1st Quarter March -12.6 % 18.04 % - -
FY   -11.81 % 6.77 % - -

Financial Statements
Crh Medical's fourth quarter 2020 Revenue $ 36.78 millions CRHM's Income Statement
Crh Medical's fourth quarter 2019 Revenue $ 30.37 millions Quarterly CRHM's Income Statement


CRHM Revenue (Quarter on Quarter Growth %)

2020
2019 2018 2017
4th Quarter December 21.2 % -0.13 % 11.45 % -
3rd Quarter September 123.49 % -0.23 % 5.12 % -
2nd Quarter June -46.64 % 4.67 % 10.78 % -
1st Quarter March -16.2 % -9.06 % - -
FY (Year on Year)   -11.81 % 6.77 % - -




Revenue fourth quarter 2020 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #48
Healthcare Sector #203
Overall #965

Revenue Y/Y Growth Statistics
High Average Low
21.12 % -24.04 % -73.06 %
(Dec 31 2020)   (Dec 31 2019)
Revenue fourth quarter 2020 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #48
Healthcare Sector #203
Overall #965
Revenue Y/Y Growth Statistics
High Average Low
21.12 % -24.04 % -73.06 %
(Dec 31 2020)   (Dec 31 2019)

Revenue by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Crh Medical's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
123.41 % 1.49 % -74.17 %
(Sep 30 2020)  


CRHM's IV. Quarter Q/Q Revenue Comment
Crh Medical Corporation achieved in the IV. Quarter 2020 above company average sequential Revenue jump of 21.2%, to $ 36.78 millions, from $30.35 millions in the third quarter.

Within Medical Equipment & Supplies industry 35 other companies have achieved higher Revenue quarter on quarter growth. While Crh Medical's Revenue growth quarter on quarter, overall rank is 783.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #36
Healthcare Sector #161
Overall #783
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #36
Healthcare Sector #161
Overall #783
Revenue Q/Q Growth Statistics
High Average Low
123.41 % 1.49 % -74.17 %
(Sep 30 2020)  


CRHM's IV. Quarter Q/Q Revenue Comment
Crh Medical Corporation achieved in the IV. Quarter 2020 above company average sequential Revenue jump of 21.2%, to $ 36.78 millions, from $30.35 millions in the third quarter.

Within Medical Equipment & Supplies industry 35 other companies have achieved higher Revenue quarter on quarter growth. While Crh Medical's Revenue growth quarter on quarter, overall rank is 783.


Crh Medical's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
Cumulative Revenue 12 Months Ending $ 106.17 $ 99.76 $ 99.82 $ 116.72 $ 120.39
Y / Y Revenue Growth (TTM) -11.81 % -18.26 % -17.06 % -0.41 % 6.77 %
Year on Year Revenue Growth Overall Ranking # 3554 # 3371 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) 6.43 % -0.07 % -14.48 % -3.04 % -1.35 %
Seq. Revenue Growth (TTM) Overall Ranking # 3443 # 1964 # 1863 # 2227 # 3446


Cumulative Revenue growth Comment
Crh Medical showed decline, but improvement compare to trailing twelve month Revenue decrease in Sep 30 2020. If the fiscal year would end in Dec 31 2020, Crh Medical's annual Revenue decline would be -11.81% year on year to $106 millions.

In the Healthcare sector 466 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 3371 to 3554.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 138
Healthcare Sector # 467
Overall # 3554

Revenue TTM Y/Y Growth Statistics
High Average Low
-11.81 %
-31.3 %
-50.8 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 138
Sector # 446
S&P 500 # 3443
Cumulative Revenue growth Comment
Crh Medical showed decline, but improvement compare to trailing twelve month Revenue decrease in Sep 30 2020. If the fiscal year would end in Dec 31 2020, Crh Medical's annual Revenue drop would be -11.81% year on year to $106 millions.

In the Healthcare sector 466 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 3371 to 3554.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 138
Healthcare Sector # 467
Overall # 3554

Revenue TTM Y/Y Growth Statistics
High Average Low
-11.81 %
-31.3 %
-50.8 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 138
Sector # 446
S&P 500 # 3443




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CRHM's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue drop for the quarter ending Dec 31 2020 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2020
Incyte Corporation36.27%$ 36.266 millions
Healthlynked Corp35.95%$ 35.949 millions
Gw Pharmaceuticals Plc35.89%$ 35.889 millions
Alphatec Holdings Inc 35.86%$ 35.862 millions
Precision Biosciences Inc35.63%$ 35.633 millions
Apyx Medical Corp35.46%$ 35.460 millions
Natera Inc 35.00%$ 35.005 millions
Viveve Medical Inc 34.18%$ 34.183 millions
Biodelivery Sciences International Inc 33.29%$ 33.287 millions
Luna Innovations Inc33.25%$ 33.248 millions
Amneal Pharmaceuticals Inc 32.96%$ 32.957 millions
Irhythm Holdings Inc 32.82%$ 32.823 millions
Affimed N v 32.58%$ 32.579 millions
Semler Scientific inc 31.93%$ 31.931 millions
Itamar Medical Ltd 31.28%$ 31.275 millions
Biodesix Inc 31.15%$ 31.145 millions
Phenomex Inc 30.84%$ 30.839 millions
Ppd Inc 30.32%$ 30.319 millions
Opiant Pharmaceuticals Inc 29.41%$ 29.407 millions
Arvinas Inc 29.07%$ 29.073 millions
Cytokinetics Incorporated28.97%$ 28.972 millions
Cardiff Oncology Inc 28.82%$ 28.817 millions
Cerus Corporation28.80%$ 28.804 millions
Remedent Inc 28.77%$ 28.767 millions
Abbott Laboratories28.71%$ 28.711 millions
Adamas Pharmaceuticals Inc28.52%$ 28.517 millions
Align Technology inc 28.43%$ 28.430 millions
Schrodinger Inc 27.87%$ 27.872 millions
Amicus Therapeutics inc 27.63%$ 27.631 millions
Cocrystal Pharma Inc 26.87%$ 26.866 millions


About Crh Medical Revenue Growth Rates (CRHM), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.